Sirnaomics Presents Positive Clinical Data of STP705 for Focal Fat Reduction
- Written by PR Newswire
The Group is Advancing the Program to a Phase II Clinical Study Data presented at the 2023 Fall Clinical Dermatology Conference
HONG KONG and GERMANTOWN, Md. and SUZHOU BIOBAY, China, Nov. 1, 2023 /PRNewswire/ -- Sirnaomics Ltd. (the "Company", Stock Code: 2257.HK, together with its subsidiaries, the "Group" or "Sirnaomics"), a leading...
Read more: Sirnaomics Presents Positive Clinical Data of STP705 for Focal Fat Reduction